1-2 of 2
Sarit Assouline
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas

Ryan D. Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri, Rebecca L. Johnston, Lauren Chong, Jasleen Grewal, Stephen Yu, Daniel Fornika, Kevin Bushell, Torsten Holm Nielsen, Tina Petrogiannis-Haliotis, Michael Crump, Axel Tosikyan, Bruno M. Grande, David MacDonald, Caroline Rousseau, Maryam Bayat, Pierre Sesques, Remi Froment, Marco Albuquerque, Yury Monczak, Kathleen Klein Oros, Celia Greenwood, Yasser Riazalhosseini, Madeleine Arseneault, Errol Camlioglu, André Constantin, Qiang Pan-Hammarstrom, Roujun Peng, Koren K. Mann, Nathalie A. Johnson
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (9): 2290–2300.
https://doi.org/10.1158/1078-0432.CCR-15-2123
Published: 01 May 2016
View articletitled, Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas
Open the PDF for Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas in another window
Includes: Supplementary data
Journal Articles

Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

Michael Andreeff, Kevin R. Kelly, Karen Yee, Sarit Assouline, Roger Strair, Leslie Popplewell, David Bowen, Giovanni Martinelli, Mark W. Drummond, Paresh Vyas, Mark Kirschbaum, Swaminathan Padmanabhan Iyer, Vivian Ruvolo, Graciela M. Nogueras González, Xuelin Huang, Gong Chen, Bradford Graves, Steven Blotner, Peter Bridge, Lori Jukofsky, Steve Middleton, Monica Reckner, Ruediger Rueger, Jianguo Zhi, Gwen Nichols, Kensuke Kojima
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (4): 868–876.
https://doi.org/10.1158/1078-0432.CCR-15-0481
Published: 14 February 2016
View articletitled, Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
Open the PDF for Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia in another window
Includes: Supplementary data